These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7214862

  • 1. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G, Tanganelli I, Signorini AM, Kristodhullu A.
    Clin Ter; 1981 Feb 28; 96(4):397-408. PubMed ID: 7214862
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A, Manninen V.
    Proc R Soc Med; 1976 Feb 28; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract] [Full Text] [Related]

  • 5. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R.
    Ther Ggw; 1974 May 28; 113(5):813-24. PubMed ID: 4603893
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A, Trezzini C, Urbinati G, Conti R.
    Clin Ter; 1979 Mar 15; 88(5):481-9. PubMed ID: 466970
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
    Lam HC, Li SH, Wang JT, Tang KT, Ho LT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Nov 15; 40(5):463-70. PubMed ID: 3332236
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic effects of bezafibrate in hyperlipidemia].
    Kunesová M, Honková M, Zeman M, Mares P, Skorepa J.
    Cas Lek Cesk; 1983 May 20; 122(20):628-31. PubMed ID: 6342789
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of bezafibrate on the carbohydrate metabolism of 17 diabetics with hyperlipidemia].
    Stratmann FW, Holler HD, Hofmann H.
    Med Welt; 1981 Feb 20; 32(8):268-71. PubMed ID: 7207168
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A, Mouton Y.
    Lille Med; 1974 Apr 20; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
    Cucinotta D, Palummeri E, Ceccato S, Passeri M.
    G Ital Cardiol; 1977 Apr 20; 7(3):248-64. PubMed ID: 858465
    [Abstract] [Full Text] [Related]

  • 18. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A, Carletta C.
    Clin Ter; 1979 Oct 15; 91(1):57-65. PubMed ID: 397871
    [No Abstract] [Full Text] [Related]

  • 19. [Hyperlipemia and pancreatitis].
    Carrillo Penso N, Carrasquero O, Medina JA.
    G E N; 1981 Oct 15; 35(1-2):15-27. PubMed ID: 6816659
    [No Abstract] [Full Text] [Related]

  • 20. [An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations].
    Füsgen I, Summa JD.
    Med Klin; 1980 Nov 07; 75(23):823-5. PubMed ID: 7442597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.